One researcher, Beverly Tchang, suggested that using multiple pathways, as Retatrutide does, is the best way forward due to obesitys complexities
doi: 10.1016/j.jff.2011.03.009
A 2023 study out of the University of British Columbia found that GLP-1 drugs were associated with an increased risk of stomach paralysis, pancreatitis and bowel obstruction
This comes down to a key pharmacology concept: Half-life matters more than the leaflet suggests In the regulatory trials, manufacturers aimed to show both insulins worked once daily a major convenience advantage over older twice-daily insulins
Another challenge is making sure you inject into the fatty tissue and not the muscle
With further research and testing, this connection could potentially be used in the future to improve lives and treatment at rehab centers like FHE Health